Cancer CareOncology & Immunotherapy

Oncology & Immunotherapy

Pioneering Cuban cancer immunotherapies recognized internationally.

Varies — typically 3–6 months of treatment
Significant survival extension documented for CIMAvax-EGF in lung cancer success rate
Cancer

About this Treatment

Cuba is a global pioneer in cancer immunotherapy, having developed innovative treatments such as CIMAvax-EGF (lung cancer), Racotumomab, and Vaxira. The Oncology & Immunotherapy program combines conventional treatments (surgery, chemotherapy, radiotherapy) with Cuban-developed immunotherapies to extend survival and improve quality of life for cancer patients.

Symptoms

Persistent lumps or swelling; unexplained weight loss; chronic fatigue; persistent pain; changes in skin or moles; difficulty swallowing; chronic cough or hoarseness; changes in bowel or bladder habits.

Treatment Benefits

Access to Cuban-developed immunotherapies not widely available elsewhere; multidisciplinary tumor board approach; integration with conventional oncology; focus on survival and quality of life; experienced oncology specialists; supportive and palliative care.

Candidate Criteria

Patients with confirmed cancer diagnosis; suitable for immunotherapy or combined treatment; adequate general condition (performance status). Biopsy reports, imaging, and pathology records required.

Procedure Overview

1) Oncology consultation and case review by multidisciplinary team. 2) Staging and biomarker assessment. 3) Treatment plan (immunotherapy alone or combined with chemo/radiotherapy/surgery). 4) Treatment administration per protocol. 5. Response monitoring with imaging. 6) Supportive care and follow-up.

Recovery Timeline

Varies by cancer type and stage; immunotherapy courses span months; follow-up continues long-term.

Risks & Considerations

Immunotherapy-related side effects (flu-like symptoms, skin reactions); conventional treatment risks; variable response; disease progression in advanced cases.

Aftercare & Follow-up

Treatment response monitoring; imaging follow-up schedule; supportive care; symptom management; coordination with home oncologist; long-term surveillance plan.

Your Patient Journey

  1. 1

    Consultation

  2. 2

    Multidisciplinary Review

  3. 3

    Staging

  4. 4

    Treatment Plan

  5. 5

    Treatment Administration

  6. 6

    Response Monitoring

  7. 7

    Long-term Follow-up

Why Choose Cuba for Oncology & Immunotherapy

Internationally recognized biotechnology

Cuba pioneered breakthroughs like Heberprot-P®, used worldwide for diabetic foot ulcers.

Highly experienced specialists

Board-certified doctors trained in Cuba's acclaimed medical education system.

Affordable all-inclusive packages

From $8,000 (immunotherapy treatment course)

Personalized patient support

Dedicated coordinators assist you from first inquiry through recovery.

Frequently Asked Questions

Common questions from patients considering this treatment. Still unsure? Contact our team anytime.

Simply fill out the evaluation form on our homepage and our team will review your case within 3-5 business days.